Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution and Peptide Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104496843B details a low-cost ubenimex synthesis route avoiding toxic resolving agents, offering significant supply chain and purity advantages for pharmaceutical manufacturers.